Integra LifeSciences Holdings Corporation
US ˙ NasdaqGS ˙ US4579852082

Introduction

This page provides a comprehensive analysis of the known insider trading history of Jerry E Corbin. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Jerry E Corbin has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:IART / Integra LifeSciences Holdings Corporation Corp VP & Corporate Controller 7,549
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Jerry E Corbin. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases IART / Integra LifeSciences Holdings Corporation - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in IART / Integra LifeSciences Holdings Corporation. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

IART / Integra LifeSciences Holdings Corporation Insider Trades
Insider Sales IART / Integra LifeSciences Holdings Corporation - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in IART / Integra LifeSciences Holdings Corporation. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2013-05-31 IART Corbin Jerry E 1,876 38.0694 3,752 19.0347 71,418 5 16.2119 -10,591 -14.83
2012-08-29 IART Corbin Jerry E 2,925 40.5767 5,850 20.2884 118,687
2012-03-12 IART Corbin Jerry E 1,900 34.5000 3,800 17.2500 65,550

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

IART / Integra LifeSciences Holdings Corporation Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Jerry E Corbin as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2014-07-02 2014-07-01 4 IART INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock
F - Taxes -135 7,549 -1.76 47.63 -6,430 359,559
2014-04-03 2014-04-02 4 IART INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock
F - Taxes -472 7,684 -5.79 45.96 -21,693 353,157
2014-04-03 2014-04-01 4 IART INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock
F - Taxes -280 8,156 -3.32 45.96 -12,869 374,850
2014-03-26 2014-03-25 4 IART INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock
F - Taxes -106 8,436 -1.24 45.77 -4,852 386,116
2013-07-02 2013-07-01 4 IART INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock
F - Taxes -135 8,542 -1.56 36.70 -4,954 313,491
2013-06-03 2013-05-31 4 IART INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock
S - Sale -1,876 8,677 -17.78 38.07 -71,418 330,328
2013-04-03 2013-04-02 4 IART INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock
F - Taxes -484 10,553 -4.39 39.42 -19,079 415,999
2013-04-03 2013-04-01 4 IART INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock
F - Taxes -690 11,037 -5.88 38.96 -26,882 430,002
2013-03-27 2013-03-25 4 IART INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock
A - Award 822 11,727 7.54
2012-08-30 2012-08-29 4 IART INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock
S - Sale -2,925 10,905 -21.15 40.58 -118,687 442,489
2012-07-03 2012-07-01 4 IART INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock
F - Taxes -132 13,830 -0.95 37.18 -4,908 514,199
2012-04-03 2012-04-02 4 IART INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock
A - Award 4,345 13,962 45.18
2012-04-03 2012-04-02 4 IART INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock
F - Taxes -940 9,617 -8.90 34.69 -32,609 333,614
2012-03-14 2012-03-12 4 IART INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock
S - Sale -1,900 10,557 -15.25 34.50 -65,550 364,216
2008-04-03 2008-04-01 4 IART INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock
A - Award 2,295 6,385 56.11
2006-11-16 3 IART INTEGRA LIFESCIENCES HOLDINGS CORP
Common Stock
1,454
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)